IPOPLUS

2,022.8

+103.6 +5.40%

18 Jun 2026

NSE Listed · Pharmaceuticals

Wockhardt Limited (WOCKPHARMA)

Volume: 67,052Avg Vol 1W: 92,811Avg Vol 1M: 1,85,58552W Range:1,086.72,422.3
₹2,022.8 5.40%
Market Cap₹31,441 Cr
Current Price₹2,022.8
Previous Close₹1,919.2
High / Low (52w)₹2,422.3 / ₹1,086.7
Volume67,052
Avg Vol (1W)92,811
Avg Vol (1M)1,85,585
Stock P/E
Book Value₹304.94
Dividend Yield0%
ROE5.75%
ROA2.31%
Revenue (TTM)
Revenue Growth7.65%
Profit Margin6.31%
Total Debt₹1,211 Cr
Shares Outstanding16 Cr
Face Value₹5
EPS (TTM)₹10.23
P/B5.33
Debt / Equity0.45
50 DMA₹1,647.64
200 DMA₹1,419.91
Day change+5.40%
Price Chart
2,022.8 35.37% · 1Y
215211002.3Cr
2025-10-01
2026-06-16

20-day avg volume: 1.9L shares

Pros
  • Company is almost debt-free.
Cons
  • Company is loss-making at the latest annual result.
Quarterly Results
MetricMar 2026Dec 2025Sept 2025Jun 2025Mar 2025Dec 2024Sept 2024Jun 2024Mar 2024Dec 2023Sept 2023Jun 2023Mar 2023Dec 2022Sept 2022Jun 2022Mar 2022Dec 2021Sept 2021Jun 2021Mar 2021Dec 2020Sept 2020Jun 2020Mar 2020
Revenue₹965 Cr₹888 Cr₹782 Cr₹738 Cr₹743 Cr₹721 Cr₹809 Cr₹739 Cr₹700 Cr₹701 Cr₹753 Cr₹644 Cr₹678 Cr₹699 Cr₹679 Cr₹595 Cr₹655 Cr₹854 Cr₹862 Cr₹860 Cr₹632 Cr₹764 Cr₹714 Cr₹598 Cr₹687 Cr
EBITDA₹217 Cr₹137 Cr₹146 Cr₹36 Cr₹26 Cr₹81 Cr₹64 Cr₹67 Cr₹-107 Cr₹-10 Cr₹41 Cr₹-25 Cr₹-21 Cr₹-19 Cr₹35 Cr₹-23 Cr₹-78 Cr₹52 Cr₹40 Cr₹58 Cr₹-123 Cr₹91 Cr₹-24 Cr₹-120 Cr₹-34 Cr
Net Profit₹166 Cr₹59 Cr₹78 Cr₹-90 Cr₹-25 Cr₹14 Cr₹-22 Cr₹-14 Cr₹-169 Cr₹-83 Cr₹-77 Cr₹-134 Cr₹-208 Cr₹-96 Cr₹-189 Cr₹-67 Cr₹-258 Cr₹-7 Cr₹34 Cr₹-13 Cr₹-93 Cr₹15 Cr₹4 Cr₹760 Cr₹48 Cr
EPS10.223.614.81-5.53-1.570.91-1.47-0.95-11.64-5.75-5.37-9.28-14.37-6.62-13.15-4.64-21.2-0.612.79-1.15-8.381.370.3268.34.34
Profit & Loss (Annual)
MetricMar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020
Revenue₹3,074 Cr₹2,881 Cr₹2,773 Cr₹3,250 Cr₹2,840 Cr₹2,883 Cr
EBITDA₹238 Cr₹-101 Cr₹-28 Cr₹71 Cr₹-177 Cr₹-66 Cr
Net Profit₹-47 Cr₹-463 Cr₹-559 Cr₹-244 Cr₹686 Cr₹-69 Cr
EPS-3.02-32.05-38.79-20.2456.87-6.25
Balance Sheet
MetricMar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020
Total Assets₹8,135 Cr₹7,649 Cr₹7,683 Cr₹8,243 Cr₹7,774 Cr₹8,179 Cr
Total Liabilities₹3,478 Cr₹3,987 Cr₹4,021 Cr₹4,041 Cr₹4,015 Cr₹5,121 Cr
Equity₹4,657 Cr₹3,662 Cr₹3,662 Cr₹4,202 Cr₹3,759 Cr₹3,057 Cr
Total Debt₹1,211 Cr₹891 Cr₹224 Cr₹355 Cr₹503 Cr₹1,241 Cr
Cash Flow
MetricMar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020
Operating₹-53 Cr₹249 Cr₹164 Cr₹510 Cr₹-170 Cr₹666 Cr
Investing₹-783 Cr₹-137 Cr₹-125 Cr₹-201 Cr₹1,470 Cr₹-156 Cr
Financing₹409 Cr₹334 Cr₹-315 Cr₹-71 Cr₹-1,171 Cr₹-680 Cr
Free Cash Flow₹-53 Cr₹249 Cr₹164 Cr₹510 Cr₹-170 Cr₹666 Cr
Shareholding
Promoter 49.08% Institutions 18.05% Public 32.83%

Prices are delayed/indicative; pros & cons are AI generated. Informational only — not investment advice. ← Back to search